TrialAnnals of hematology2020

Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma.

Andrew Davies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.